Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Agent Capital
AddedFeb 13, 2024
UpdatedJul 16, 2026
Agent Capital

Agent Capital

Operating

Agent Capital: A healthcare-focused venture capital firm investing in innovative solutions for unmet patient needs.

Location
Waltham, MA, US
Founded
2016
Firm
Compare
Portfolio
Employees

Agent Capital is a healthcare investment firm focused on novel technologies and therapeutics that address unmet patient need.

Their investment areas of focus are new products and technologies for oncology, immunology, neurology and rare disease indications. They make direct equity investments across... Read more

Agent Capital - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments35
Current Portfolio Count24
Total Portfolio Exits1

Top Investment Stages

Series B12 (35.3%)
Series A9 (26.5%)
Series C5 (14.7%)
Series Unknown5 (14.7%)
Seed3 (8.8%)

Stage Mix

Series B 35%Series A 26%Series C 15%Series Unknown 15%Seed 9%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Flare Therapeutics logo

Flare Therapeutics

Cantai Therapeutics logo

Cantai Therapeutics

ViTToria Biotherapeutics logo

ViTToria Biotherapeutics

Jana Care logo

Jana Care

Star Therapeutics logo

Star Therapeutics

Foresight Diagnostics logo

Foresight Diagnostics

Orbital Therapeutics logo

Orbital Therapeutics

Palvella Therapeutics logo

Palvella Therapeutics

Carisma Therapeutics logo

Carisma Therapeutics

Carbon Biosciences logo

Carbon Biosciences

Affini-T Therapeutics logo

Affini-T Therapeutics

Cyrus Biotechnology logo

Cyrus Biotechnology

Immunitas Therapeutics logo

Immunitas Therapeutics

Interius BioTherapeutics logo

Interius BioTherapeutics

Entrada Therapeutics logo

Entrada Therapeutics

Mediar Therapeutics logo

Mediar Therapeutics

Metagenomi logo

Metagenomi

Pliant Therapeutics logo

Pliant Therapeutics

Verge Genomics logo

Verge Genomics

Skyhawk Therapeutics logo

Skyhawk Therapeutics

Precision BioSciences logo

Precision BioSciences

Hinge Bio logo

Hinge Bio

Aptinyx logo

Aptinyx

Orbus Therapeutics logo

Orbus Therapeutics

Freenome logo

Freenome

Agent Capital - Similar Investment Firms

CareCapital logo

CareCapital

CyberAgent Capital logo

CyberAgent Capital

GT Healthcare Capital Partners logo

GT Healthcare Capital Partners

HealthTrend Capital logo

HealthTrend Capital

healthtrendcap.com

Amicus Capital Partners logo

Amicus Capital Partners

Patient Square Capital logo

Patient Square Capital

SilverArc Capital logo

SilverArc Capital

Care Capital logo

Care Capital

carecapital.com

BioImpact Capital logo

BioImpact Capital

Pathocapital logo

Pathocapital

Adjuvant Capital logo

Adjuvant Capital

HealthQuest Capital logo

HealthQuest Capital

NeuroVentures Capital logo

NeuroVentures Capital

neuroventures.com

New Capital Fund logo

New Capital Fund

Transhuman Capital logo

Transhuman Capital

Agent Capital - Classification

Also Known As
  • Agent'S Capital, LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end